ETFs positioned on Johnson & Johnson

Name Weight AuM 1st Jan change Investor Rating
14.01% 335 M€ -4.17% -
12.91% 30 M€ +2.22% -
5.67% 0 M€ -.--% -
4.85% 38 M€ +7.01% -
4.35% 0 M€ -72.95% -
3.66% 145 M€ +1.91%
3.20% 0 M€ -.--% -
2.57% 0 M€ -.--% -
2.55% 515 M€ +0.70%
2.31% 0 M€ +17.41%
1.99% 738 M€ +2.22%
1.96% 0 M€ +1.31%
1.90% 0 M€ +14.69% -
1.88% 0 M€ -3.37%
1.86% 55 M€ +3.02% -
1.80% 0 M€ -.--% -
1.71% 0 M€ -.--%
1.59% 0 M€ +15.64% -
1.58% 0 M€ +14.54% -
1.58% 0 M€ +0.04%
1.58% 419 M€ +1.88%
1.58% 0 M€ -.--%
1.54% 0 M€ +11.32%
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.3%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.7%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2023, Johnson & Johnson has 61 manufacturing facilities located in the United States (23), North America (5), Europe (20), Africa and Asia/Pacific (13). The United States accounts for 54.5% of net sales.
Employees
131,900
Calendar
More about the company
Trading Rating
Investor Rating
ESG MSCI
A
surperformance-ratings-light-chart JOHNSON-JOHNSONMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.27USD
Average target price
168.52USD
Spread / Average Target
+16.00%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. ETFs Johnson & Johnson